Allurion Technologies (NYSE:ALUR) Receives Neutral Rating from Chardan Capital

Allurion Technologies (NYSE:ALUR)‘s stock had its “neutral” rating reissued by analysts at Chardan Capital in a research report issued to clients and investors on Thursday,Benzinga reports.

Other equities research analysts have also issued reports about the company. Zacks Research upgraded Allurion Technologies to a “hold” rating in a research note on Tuesday, August 12th. Wall Street Zen lowered Allurion Technologies from a “hold” rating to a “strong sell” rating in a research note on Saturday, August 16th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Allurion Technologies in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Allurion Technologies has an average rating of “Hold” and a consensus price target of $9.25.

Allurion Technologies Stock Performance

Shares of NYSE ALUR opened at $1.39 on Thursday. The firm has a market capitalization of $10.79 million, a price-to-earnings ratio of -0.13 and a beta of -0.46. Allurion Technologies has a one year low of $1.29 and a one year high of $16.81. The business has a fifty day simple moving average of $1.91 and a 200 day simple moving average of $2.36.

Allurion Technologies (NYSE:ALUR) last announced its quarterly earnings results on Wednesday, November 12th. The company reported ($1.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.45) by $1.27. The business had revenue of $2.66 million during the quarter, compared to the consensus estimate of $2.05 million. On average, research analysts anticipate that Allurion Technologies will post -9.96 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Allurion Technologies stock. XTX Topco Ltd raised its stake in Allurion Technologies, Inc. (NYSE:ALUR) by 43.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,670 shares of the company’s stock after acquiring an additional 5,633 shares during the quarter. XTX Topco Ltd owned about 0.25% of Allurion Technologies worth $45,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 21.39% of the company’s stock.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.